|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
EP1087937A1
(en)
|
1998-06-17 |
2001-04-04 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
NZ515087A
(en)
|
1999-04-28 |
2003-11-28 |
Aventis Pharma Gmbh |
Tri-aryl acid derivatives as PPAR receptor ligands
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
CA2383135C
(en)
|
1999-08-23 |
2010-11-30 |
Hiroyuki Hirai |
Method of identifying properties of substance with respect to human prostaglandin d2 receptors
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
JP4279561B2
(ja)
|
2001-05-23 |
2009-06-17 |
メルク フロスト カナダ リミテツド |
プロスタグランジンＤ２受容体拮抗薬としてのジヒドロピロロ［１，２−ａ］インドールおよびテトラヒドロピリド［１，２−ａ］−インドール誘導体
|
|
WO2003006011A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
IL160845A0
(en)
*
|
2001-09-14 |
2004-08-31 |
Tularik Inc |
Linked biaryl compounds
|
|
JP4332151B2
(ja)
|
2002-10-30 |
2009-09-16 |
メルク フロスト カナダ リミテツド |
ピリドピロリジンおよびピリドインドリジン誘導体
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
ES2401079T3
(es)
|
2002-12-20 |
2013-04-16 |
Amgen Inc. |
Moduladores del asma y de la inflamación alérgica
|
|
ATE316077T1
(de)
|
2003-04-25 |
2006-02-15 |
Actimis Pharmaceuticals Inc |
Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
|
|
EP1675826A1
(en)
|
2003-10-14 |
2006-07-05 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
WO2005051373A1
(ja)
|
2003-11-26 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
受容体機能調節剤
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
EP1737811B1
(en)
|
2004-04-13 |
2016-08-10 |
Merck Sharp & Dohme Corp. |
Cetp inhibitors
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006018325A1
(en)
|
2004-08-17 |
2006-02-23 |
Galderma Research & Development, S.N.C. |
Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions
|
|
WO2006034419A2
(en)
|
2004-09-21 |
2006-03-30 |
Athersys, Inc. |
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
EP1814865A4
(en)
|
2004-09-21 |
2009-09-02 |
Wyeth Corp |
BENZIMIDAZOL ACETIC ACIDS WITH CRTH2 RECEPTOR ANTAGONISM AND ITS APPLICATIONS
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
AR053784A1
(es)
|
2004-11-23 |
2007-05-23 |
Pfizer Prod Inc |
Compuestos y derivados tetrazolicos de dibencil amina. composiciones farmaceuticas.
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
EP1939175B1
(en)
|
2005-09-27 |
2017-03-01 |
Shionogi&Co., Ltd. |
Sulfonamide derivative having pgd2 receptor antagonistic activity
|
|
US8148572B2
(en)
|
2005-10-06 |
2012-04-03 |
Astrazeneca Ab |
Compounds
|
|
ES2380683T3
(es)
*
|
2005-12-15 |
2012-05-17 |
Astrazeneca Ab |
Difenil-éteres, -amidas, -sulfuros y - metanos sustituidos para el tratamiento de la enfermedad respiratoria
|
|
HUE031972T2
(en)
|
2005-12-29 |
2017-08-28 |
Celtaxsys Inc |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
JP2009539881A
(ja)
*
|
2006-06-09 |
2009-11-19 |
アイコス コーポレイション |
Ｄｐ−２アンタゴニストとしての置換フェニル酢酸
|
|
MX2009001876A
(es)
*
|
2006-08-21 |
2009-03-06 |
Array Biopharma Inc |
Derivados de acido fenoxifenilacetico 4-sustituidos.
|
|
CN101765585B
(zh)
|
2007-06-12 |
2017-03-15 |
尔察祯有限公司 |
抗菌剂
|
|
AU2008270438B2
(en)
|
2007-07-02 |
2013-10-10 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as CCR2 receptor antagonists
|
|
CN101801952A
(zh)
|
2007-10-01 |
2010-08-11 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr受体拮抗剂的n-杂环联芳基甲酰胺类化合物
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
NZ587251A
(en)
|
2008-01-18 |
2011-12-22 |
Oxagen Ltd |
Indole derivatives having CRTH2 antagonist activity
|
|
EP2257524B1
(en)
|
2008-02-01 |
2016-01-06 |
Brickell Biotech, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
UA98839C2
(en)
|
2008-02-01 |
2012-06-25 |
Панмира Фармасьютикалз, Ллк. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
JP2011512359A
(ja)
|
2008-02-14 |
2011-04-21 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物
|
|
JP2011518130A
(ja)
|
2008-04-02 |
2011-06-23 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアミノアルキルフェニルアンタゴニスト
|
|
WO2010003120A2
(en)
*
|
2008-07-03 |
2010-01-07 |
Amira Pharmaceuticals, Inc. |
Antagonists of prostaglandin d2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
KR20120046762A
(ko)
|
2009-07-31 |
2012-05-10 |
판미라 파마슈티칼스, 엘엘씨 |
Ｄｐ2 수용체 길항제의 피부 제형
|
|
EP2461809A4
(en)
|
2009-07-31 |
2013-06-19 |
Panmira Pharmaceuticals Llc |
OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONSITES
|